Foundation Medicine Announces Strategic Collaboration with Arvinas

Initial Goal of Collaboration is to Develop FoundationOne®Liquid CDx as a Companion Diagnostic for Bavdegalutamide (ARV-110), Arvinas’ Investigational Androgen Receptor-Targeting PROTAC® Protein DegraderCAMBRIDGE, Mass.--(BUSINESS WIRE)--#ASCO22--Today Foundation Medicine, Inc., a pioneer in molecular profiling for...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Foundationone Cdx ,Sanket Agrawal ,Aaron Peck ,Foundation Medicine ,Linkedin ,Twitter ,Arvinas Inc ,Foundation Medicine Inc ,Initial Goal ,Develop Foundationone ,Companion Diagnostic ,Today Foundation Medicine ,Intended Use ,Essential Partner ,